Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 22012.00 Crore) operating in Pharmaceuticals sector.
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 519.60 Crore, up 23.24 % from last quarter Sales of Rs 421.60 Crore and up 11.84 % from last year same quarter Sales of Rs 464.60 Crore Company reported net profit after tax of Rs 84.10 Crore in latest quarter.
The management has maintained its guidance for double-digit revenue growth on the back of continuous client additions, an extension of existing contracts, increasing manufacturing and biological contributions besides currency tailwinds. With elite client additions like Amgen, Zoetis, Herbalife, GSK, etc, and multiple year extension of BMS, Baxter contracts, the company remains well poised to capture opportunities in the global CRO space
#Syngene #International #share #price #Buy #Syngene #International #target #price #ICICI #Direct